Common genetic variation indicates separate etiologies for periventricular and deep white matter hyperintensities

We conducted a genome-wide association meta-analysis of two ischemic white matter disease subtypes in the brain, periventricular and deep white matter hyperintensities (PVWMH and DWMH). In 26,654 participants, we found 10 independent genome-wide significant loci only associated with PVWMH, four of which have not been described previously for total WMH burden (16q24.2, 17q21.31, 10q23.1, 7q36.1). Additionally, in both PVWMH and DWMH we observed the previous association of the 17q25.1 locus with total WMH. We found that both phenotypes have shared but also distinct genetic architectures, consistent with both different underlying and related pathophysiology. PVWMH had more extensive genetic overlap with small vessel ischemic stroke, and unique associations with several loci implicated in ischemic stroke. DWMH were characterized by associations with loci previously implicated in vascular as well as astrocytic and neuronal function. Our study confirms the utility of these phenotypes and identifies new candidate genes associated only with PVWMH.

[1]  I. Rosenberg,et al.  MAT1A variants are associated with hypertension, stroke, and markers of DNA damage and are modulated by plasma vitamin B-6 and folate. , 2010, The American journal of clinical nutrition.

[2]  Jun Wang,et al.  SNPnexus: assessing the functional relevance of genetic variation to facilitate the promise of precision medicine , 2018, Nucleic Acids Res..

[3]  J. Ikeda,et al.  Cyclin-dependent kinases as a therapeutic target for stroke. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Hofman,et al.  Silent Brain Infarcts and White Matter Lesions Increase Stroke Risk in the General Population: The Rotterdam Scan Study , 2003, Stroke.

[5]  Benjamin F. J. Verhaaren,et al.  Replication Study of Chr17q25 With Cerebral White Matter Lesion Volume , 2011, Stroke.

[6]  Karen J. Ferguson,et al.  Enlarged Perivascular Spaces on MRI Are a Feature of Cerebral Small Vessel Disease , 2010, Stroke.

[7]  S. Scherer,et al.  A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2 , 2001, Nature Genetics.

[8]  M. Kubo,et al.  Genetic Variants of RAMP2 and CLR are Associated with Stroke , 2017, Journal of atherosclerosis and thrombosis.

[9]  B. Bein,et al.  Remote ischemic preconditioning regulates HIF-1α levels, apoptosis and inflammation in heart tissue of cardiosurgical patients: a pilot experimental study , 2012, Basic Research in Cardiology.

[10]  G. Boss,et al.  A DNA Polymerase-α·Primase Cofactor with Homology to Replication Protein A-32 Regulates DNA Replication in Mammalian Cells* , 2009, Journal of Biological Chemistry.

[11]  J. Reuck,et al.  The Human Periventricular Arterial Blood Supply and the Anatomy of Cerebral Infarctions , 1971 .

[12]  V. Vieland,et al.  Validation of a microRNA target site polymorphism in H3F3B that is potentially associated with a broad schizophrenia phenotype , 2018, PloS one.

[13]  Andrew D. Johnson,et al.  Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes , 2018, Nature Genetics.

[14]  C. Sudlow,et al.  Genetic variation at 16q24.2 is associated with small vessel stroke , 2017, Annals of neurology.

[15]  S. Hadano,et al.  A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2 , 2001, Nature Genetics.

[16]  E. Meinl,et al.  Myofibrillar myopathy with arrhythmogenic right ventricular cardiomyopathy 7: corroboration and narrowing of the critical region on 10q22.3 , 2008, European Journal of Human Genetics.

[17]  Lorna M. Lopez,et al.  Multiethnic Genome-Wide Association Study of Cerebral White Matter Hyperintensities on MRI , 2015, Circulation. Cardiovascular genetics.

[18]  Y. Kuang,et al.  Impact of interaction between the G870A and EFEMP1 gene polymorphism on glioma risk in Chinese Han population , 2017, Oncotarget.

[19]  F. Fazekas,et al.  Pathologic correlates of incidental MRI white matter signal hyperintensities , 1993, Neurology.

[20]  J. O'Brien,et al.  White Matter Lesions in an Unselected Cohort of the Elderly: Molecular Pathology Suggests Origin From Chronic Hypoperfusion Injury , 2006, Stroke.

[21]  Wei Wen,et al.  White matter hyperintensities in mid-adult life , 2008, Current opinion in psychiatry.

[22]  Zoltán Kutalik,et al.  Quality control and conduct of genome-wide association meta-analyses , 2014, Nature Protocols.

[23]  Michael Boehnke,et al.  LocusZoom: regional visualization of genome-wide association scan results , 2010, Bioinform..

[24]  M. Dichgans,et al.  Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging , 2013, The Lancet Neurology.

[25]  Erdogan Taskesen,et al.  Functional mapping and annotation of genetic associations with FUMA , 2017, Nature Communications.

[26]  P. Visscher,et al.  GCTA: a tool for genome-wide complex trait analysis. , 2011, American journal of human genetics.

[27]  Ellen T. Gelfand,et al.  A Novel Approach to High-Quality Postmortem Tissue Procurement: The GTEx Project , 2015, Biopreservation and biobanking.

[28]  Heping Gu,et al.  The association between an endothelial nitric oxide synthase gene polymorphism and coronary heart disease in young people and the underlying mechanism. , 2017, Molecular medicine reports.

[29]  Ping Li,et al.  Specific Inhibition of Acyl-CoA Oxidase-1 by an Acetylenic Acid Improves Hepatic Lipid and Reactive Oxygen Species (ROS) Metabolism in Rats Fed a High Fat Diet* , 2017, The Journal of Biological Chemistry.

[30]  Michael E. Greenberg,et al.  A Calcium-Responsive Transcription Factor, CaRF, that Regulates Neuronal Activity-Dependent Expression of BDNF , 2002, Neuron.

[31]  C. Labelle-Dumais,et al.  COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets , 2012, Human molecular genetics.

[32]  Anbupalam Thalamuthu,et al.  White Matter Hyperintensities Are Under Strong Genetic Influence , 2016, Stroke.

[33]  Jennifer L. Cuzzocreo,et al.  Age differences in periventricular and deep white matter lesions , 2015, Neurobiology of Aging.

[34]  Bogdan Pasaniuc,et al.  Local genetic correlation gives insights into the shared genetic architecture of complex traits , 2016, bioRxiv.

[35]  C. Jack,et al.  Blood Pressure and White-Matter Disease Progression in a Biethnic Cohort: Atherosclerosis Risk in Communities (ARIC) Study , 2010, Stroke.

[36]  Nicholette D. Palmer,et al.  Exome Chip Analysis Identifies Low-Frequency and Rare Variants in MRPL38 for White Matter Hyperintensities on Brain Magnetic Resonance Imaging , 2018, Stroke.

[37]  Nick C Fox,et al.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.

[38]  K. Kadler,et al.  Chemical chaperone treatment reduces intracellular accumulation of mutant collagen IV and ameliorates the cellular phenotype of a COL4A2 mutation that causes haemorrhagic stroke , 2013, Human molecular genetics.

[39]  M. Fornage,et al.  Genome‐wide association studies of cerebral white matter lesion burden , 2011, Annals of neurology.

[40]  Ludovica Griffanti,et al.  Classification and characterization of periventricular and deep white matter hyperintensities on MRI: A study in older adults , 2017, NeuroImage.

[41]  Rajendra K. Sharma,et al.  Expression of N-myristoyltransferase in Human Brain Tumors , 2004, Neurochemical Research.

[42]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[43]  Jie Huang,et al.  Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function , 2017, The Journal of clinical investigation.

[44]  Kaarin J Anstey,et al.  White matter hyperintensities in the forties: Their prevalence and topography in an epidemiological sample aged 44–48 , 2009, Human brain mapping.

[45]  M. Daly,et al.  LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.

[46]  C. Sudlow,et al.  Enlarged perivascular spaces and cerebral small vessel disease , 2013, International journal of stroke : official journal of the International Stroke Society.

[47]  Joseph K. Pickrell.  Joint analysis of functional genomic data and genome-wide association studies of 18 human traits , 2013, bioRxiv.

[48]  M. Dichgans,et al.  Genetic Study of White Matter Integrity in UK Biobank (N=8448) and the Overlap With Stroke, Depression, and Dementia , 2018, Stroke.

[49]  C. Sudlow,et al.  Genetic variation in PLEKHG1 is associated with white matter hyperintensities (n = 11,226) , 2019, Neurology.

[50]  Gunhild Waldemar,et al.  Deterioration of Gait and Balance over Time: The Effects of Age-Related White Matter Change - The LADIS Study , 2013, Cerebrovascular Diseases.

[51]  Hui Zhang,et al.  White matter microstructure pathology in classic galactosemia revealed by neurite orientation dispersion and density imaging , 2014, Journal of Inherited Metabolic Disease.

[52]  C. Sudlow,et al.  Genome‐wide meta‐analysis identifies 3 novel loci associated with stroke , 2018, Annals of neurology.

[53]  D. Maulik,et al.  Adiporedoxin suppresses endothelial activation via inhibiting MAPK and NF-κB signaling , 2016, Scientific Reports.

[54]  L. McEvoy,et al.  White matter disease in midlife is heritable, related to hypertension, and shares some genetic influence with systolic blood pressure , 2016, NeuroImage: Clinical.

[55]  Kaitlin M. Fitzpatrick,et al.  Genome-wide meta-analysis of cerebral white matter hyperintensities in patients with stroke , 2016, Neurology.

[56]  Gabi Kastenmüller,et al.  SNiPA: an interactive, genetic variant-centered annotation browser , 2014, Bioinform..

[57]  J. O'Brien,et al.  Microarray RNA Expression Analysis of Cerebral White Matter Lesions Reveals Changes in Multiple Functional Pathways , 2009, Stroke.

[58]  C. Iadecola,et al.  The Pathobiology of Vascular Dementia , 2013, Neuron.

[59]  Philip Scheltens,et al.  Relationship between periventricular and deep white matter lesions and depressive symptoms in older people. The LADIS Study , 2006, International journal of geriatric psychiatry.

[60]  C. Boucheix,et al.  Regulation of the trafficking and the function of the metalloprotease ADAM10 by tetraspanins. , 2017, Biochemical Society transactions.

[61]  Lisa J. Martin,et al.  Common variation in COL4A1/COL4A2 is associated with sporadic cerebral small vessel disease , 2015, Neurology.

[62]  C. Sudlow,et al.  COL4A2 is associated with lacunar ischemic stroke and deep ICH: Meta-analyses among 21,500 cases and 40,600 controls , 2017, Neurology.

[63]  Ka Sing Wong,et al.  Effects of statins on the progression of cerebral white matter lesion , 2009, Journal of Neurology.

[64]  A. Hofman,et al.  Silent brain infarcts and the risk of dementia and cognitive decline. , 2003, The New England journal of medicine.

[65]  W. M. van der Flier,et al.  Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[66]  A. Antonacopoulou,et al.  POLR2F, ATP6V0A1 and PRNP expression in colorectal cancer: new molecules with prognostic significance? , 2008, Anticancer research.

[67]  J. Marchini,et al.  Genome-wide association studies of brain imaging phenotypes in UK Biobank , 2018, Nature.

[68]  Joseph K. Pickrell,et al.  Detection and interpretation of shared genetic influences on 42 human traits , 2015, Nature Genetics.

[69]  C. Has.  The "Kelch" Surprise: KLHL24, a New Player in the Pathogenesis of Skin Fragility. , 2017, The Journal of investigative dermatology.

[70]  Lucas O. Müller,et al.  Blood pressure gradients in cerebral arteries: a clue to pathogenesis of cerebral small vessel disease , 2017, Stroke and Vascular Neurology.

[71]  C. Lewis,et al.  Genetic discovery in multi-ethnic populations , 2016, European Journal of Human Genetics.

[72]  Nick C Fox,et al.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.

[73]  Joris M. Mooij,et al.  MAGMA: Generalized Gene-Set Analysis of GWAS Data , 2015, PLoS Comput. Biol..

[74]  Carole Dufouil,et al.  Antihypertensive Treatment and Change in Blood Pressure Are Associated With the Progression of White Matter Lesion Volumes: The Three-City (3C)–Dijon Magnetic Resonance Imaging Study , 2011, Circulation.

[75]  J. Dudink,et al.  COL4A2 mutation associated with familial porencephaly and small-vessel disease , 2012, European Journal of Human Genetics.

[76]  Chinthasagar Bastian,et al.  NOS3 Inhibition Confers Post-Ischemic Protection to Young and Aging White Matter Integrity by Conserving Mitochondrial Dynamics and Miro-2 Levels , 2018, The Journal of Neuroscience.